Avid Technology Announces Q2 2017 Results and Issues Q3 2017 Guidance
Aug 03, 2017 20:41 pm UTC| Business
Exceeded Guidance for Adjusted Free Cash Flow; In Line on All Other Metrics Strong Revenue Backlog and Continued Expense Management Creates Better Visibility Continued Execution Drives Positive Free Cash Flow and...
Aug 03, 2017 20:30 pm UTC| Business
WILMINGTON, Del., Aug. 03, 2017 -- WSFS Financial Corporation (NASDAQ:WSFS), the parent company of WSFS Bank, today announced that the Board of Directors has elected Mark A. Turner as Chairman of the Board. This...
Enstar Group Limited Reports Second Quarter Results
Aug 03, 2017 20:30 pm UTC| Business
HAMILTON, Bermuda, Aug. 03, 2017 -- Enstar Group Limited (Nasdaq:ESGR) filed its quarterly report on Form 10-Q with the SEC today, reporting its earnings and financial position for the three and six months ended...
Broadridge Appoints Tim Gokey President
Aug 03, 2017 20:30 pm UTC| Business
LAKE SUCCESS, N.Y., Aug. 03, 2017 -- Broadridge Financial Solutions, Inc. (NYSE:BR) today announced that Tim Gokey has been appointed President, effective September 1, 2017. Mr. Gokey is assuming the title of President...
Vectren Corporation Reports Second Quarter 2017 Results; Affirms 2017 Guidance
Aug 03, 2017 20:30 pm UTC| Business
EVANSVILLE, Ind., Aug. 03, 2017 -- Vectren Corporation (NYSE:VVC) today reported second quarter 2017 net income of $37.6 million, or $0.45 per share, compared to net income of $32.3 million, or $0.39 per share, in the...
Ascendis Pharma A/S Announces Second Quarter 2017 Financial Results Conference Call on August 18
Aug 03, 2017 20:30 pm UTC| Business
COPENHAGEN, Denmark, Aug. 03, 2017 -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today...
Dova Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 10, 2017
Aug 03, 2017 20:30 pm UTC| Business
DURHAM, N.C., Aug. 03, 2017 -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is a high unmet need,...